Cardiac Implantable Electronic Device Market, By Type (Implantable Pacemakers and External Pacemakers), By End User (Hospitals, Specialty Clinics, and Ambulatory Care Settings), and By Region (North America, Latin America, Europe, Asia Pacific, Middle Eas

Cardiac Implantable Electronic Device Market, By Type (Implantable Pacemakers and External Pacemakers), By End User (Hospitals, Specialty Clinics, and Ambulatory Care Settings), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Cardiac implants are devices that are implanted in the heart tissue, in order to control irregular heart function. Cardiac implants such as pacemakers, defibrillator implants, and cardiac rhythm monitoring implants are available in the market to treat cardiac dysfunction such as heart rhythm disorders, arrhythmias, and other heart related disorders. These cardiac implants are majorly prescribed to patients with heart failure. Cardiac implants have been developed with innovative technical features in the recent years, which has improved quality of life in patients with heart failure.
Market Dynamics
The increasing incidence of cardiac arrhythmia is expected to drive growth of the cardiac implantable electronic device market. For instance, according to the Anesthesia Patient Safety Foundation 2013, around 14.4 million patients in the U.S. suffer from cardiac arrhythmia and it accounts for around 40,700 deaths, annually.
However, factors such as chances of infections associated with the installation of pacemakers in cardiac patients can hamper the cardiac implantable electronic device market growth. Pacemaker surgery can also lead to various complications such as bleeding, bruising or swelling at the of area of pacemaker implantation leading to blood vessel or nerve damage, which in turn can reduce the adoption of cardiac implants by patients.
Key features of the study:
This report provides in-depth analysis of the global cardiac implantable electronic device market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global cardiac implantable electronic device market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and strategies
Key players covered as a part of this study include Medtronic plc., Biotronik, Boston Scientific Corporation, Shree Pacetronix Ltd., CCC Medical Devices, Cook Group Incorporated, Braile Biomédica, Abbott Laboratories, Sorin Group, Osypka Medical GmbH, Galix Biomedical Instrumentation Inc., and Oscor Inc.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global cardiac implantable electronic device market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for cardiac implantable electronic device market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:
Global Cardiac Implantable Electronic Device Market, By Type:
Implantable Pacemakers
External Pacemakers
Global Cardiac Implantable Electronic Device Market, By Application:
Arrhythmia
Heart Block
Others
Global Cardiac Implantable Electronic Device Market, By End User:
Hospitals
Specialty Clinics
Ambulatory Care Settings
Global Cardiac Implantable Electronic Device Market, By Region:
North America
By Country:
U.S.
Canada
By Type:
Implantable Pacemakers
External Pacemakers
By Application
Arrhythmia
Heart Block
Others
By End User:
Hospitals
Specialty Clinics
Ambulatory Care Settings
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Type:
Implantable Pacemakers
External Pacemakers
By Application
Arrhythmia
Heart Block
Others
By End User:
Hospitals
Specialty Clinics
Ambulatory Care Settings
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Type:
Implantable Pacemakers
External Pacemakers
By Application
Arrhythmia
Heart Block
Others
By End User:
Hospitals
Specialty Clinics
Ambulatory Care Settings
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Type:
Implantable Pacemakers
External Pacemakers
By Application
Arrhythmia
Heart Block
Others
By End User:
Hospitals
Specialty Clinics
Ambulatory Care Settings
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Type:
Implantable Pacemakers
External Pacemakers
By Application
Arrhythmia
Heart Block
Others
By End User:
Hospitals
Specialty Clinics
Ambulatory Care Settings
Africa
By Country/Region:
South Africa
Central Africa
North Africa
By Type:
Implantable Pacemakers
External Pacemakers
By Application
Arrhythmia
Heart Block
Others
By End User:
Hospitals
Specialty Clinics
Ambulatory Care Settings
Company Profiles
Medtronic plc
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Biotronik
Boston Scientific Corporation
Shree Pacetronix Ltd.
CCC Medical Devices
Cook Group Incorporated
Braile Biomédica
Abbott Laboratories
Sorin Group
Osypka Medical GmbH
Galix Biomedical Instrumentation Inc.
Oscor Inc.
“*” marked represents similar segmentation in other categories in the respective section.